| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |